McMahon CM, Canaani J, Rea B, Sargent RL, Morrissette JJD, Lieberman DB, Watt CD, Schwartz GW, Faryabi RB, Ferng TT, Shah NP, Smith CC, Caroll M, and Perl AE: Mechanisms of acquired resistance to Gilteritinib therapy in relapsed and refractory FLT3-mutated acute myeloid leukemia. Blood 130 (s1): 295,2017.
Hatem J, Schrank-Hacker AM, Watt CD, Morrissette JJ, Rubin AI, Kim EJ, Nasta SD, Wasik MA, Bogusz AM.: Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report. Diagnostic Pathology 11 : 137,2016.
Surrey LF, Smith JR, Lubin D, Van Deerlin V, Watt CD: Analytic Approach for Complete and Mixed Engraftment Analysis using Commercial Software. The Journal of Molecular Diagnostics 18 (6): 1030,2016.
Li Y, Alby K, Watt CD, Roth JJ: Integration of rapid molecular testing for influenza and RSV into existing diagnostic workflow. The Journal of Molecular Diagnostics 18 (6): 979,2016.
Press RD, Watt CD, Cai L, Van Deerlin VM, Roth JJ, Gentile C, Loren A, and Eickelberg G: BCR-ABL1 molecular responses at 12-18 months predict long-term event-free survival in patients with tyrosine kinase inhibitor (TKI)-treated chronic myelogenous leukemia (CML). The Journal of Molecular Diagnostics 18 (6): 964,2016.
Roth JJ, Windon AL, Strubinger J, Carlin A, Gentile C, Watt CD, McGrath CM, Van Deerlin VM: Improvements in workflow after verification and implementation of the cobas® HPV Test. The Journal of Molecular Diagnostics 18 (6): 970,2016.
Nybakken G, Canaani J, Darshan R, Morrissette J, Watt CD, Shah N, Smith C, Bagg A, Carroll M, and Perl A: Quizartinib elicits differential responses that correlate with karyotype and genotype of the leukemic clone. Leukemia 30 (6): 1422-5,2016.
Canaani J, Rea B, Sargent R, Morrissette J, Lieberman D, Watt CD, Carroll M, Perl A: Differentiation response to gilteritinib (ASP2215) in relapsed/refractory FLT3 mutated acute myeloid leukemia patients is associated with co-mutations in NPM1 and DNMT3A. Haematologica, 2016 European Hematology Association Annual Congress 101 (S1): 2016.
Hiemenz MC, Kadauke S, Lieberman DB, Roth DB, Zhao J, Watt CD, Daber RD, Morrissette JJ: Building a robust tumor profiling program: Synergy between next-generation sequencing and targeted single-gene testing.
PLoS One 11 (4): e0152851,2016.
Cambor C, Roth D, Loundas C, Heuer M, Watt C, Montone K, Sesok-Pizzini D: Development of a dynamic leadership curriculum to enhance residency education in pathology and laboratory medicine. Modern Pathology 29 (S2): 2016.